These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9541615)

  • 21. Analysis of the respiratory syncytial virus fusion protein using monoclonal and polyclonal antibodies.
    Walsh EE; Cote PJ; Fernie BF; Schlesinger JJ; Brandriss MW
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():505-13. PubMed ID: 2419491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Localization and fine mapping of antigenic sites on the nucleocapsid protein N of porcine reproductive and respiratory syndrome virus with monoclonal antibodies.
    Meulenberg JJ; van Nieuwstadt AP; van Essen-Zandbergen A; Bos-de Ruijter JN; Langeveld JP; Meloen RH
    Virology; 1998 Dec; 252(1):106-14. PubMed ID: 9875321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mapping of a fusion related epitope of the respiratory syncytial virus fusion protein.
    Paradiso PR; Hu BT; Arumugham R; Hildreth S
    Vaccine; 1991 Apr; 9(4):231-7. PubMed ID: 1711741
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recombinant low-seroprevalent adenoviral vectors Ad26 and Ad35 expressing the respiratory syncytial virus (RSV) fusion protein induce protective immunity against RSV infection in cotton rats.
    Widjojoatmodjo MN; Bogaert L; Meek B; Zahn R; Vellinga J; Custers J; Serroyen J; Radošević K; Schuitemaker H
    Vaccine; 2015 Oct; 33(41):5406-5414. PubMed ID: 26319741
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.
    Ulbrandt ND; Ji H; Patel NK; Barnes AS; Wilson S; Kiener PA; Suzich J; McCarthy MP
    J Gen Virol; 2008 Dec; 89(Pt 12):3113-3118. PubMed ID: 19008400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterisation of multiple linear B cell protectopes in the respiratory syncytial virus G protein.
    Power UF; Plotnicky-Gilquin H; Goetsch L; Champion T; Beck A; Haeuw JF; Nguyen TN; Bonnefoy JY; Corvaïa N
    Vaccine; 2001 Mar; 19(17-19):2345-51. PubMed ID: 11257359
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Monoclonal antibodies to the large glycoproteins of respiratory syncytial virus: possible evidence for several functional antigenic sites.
    Tsutsumi H; Flanagan TD; Ogra PL
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2161-7. PubMed ID: 2440982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antigenic structure of the central conserved region of protein G of bovine respiratory syncytial virus.
    Langedijk JP; Meloen RH; Taylor G; Furze JM; van Oirschot JT
    J Virol; 1997 May; 71(5):4055-61. PubMed ID: 9094683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic peptides corresponding to the F protein of RSV stimulate murine B and T cells but fail to confer protection.
    Trudel M; Stott EJ; Taylor G; Oth D; Mercier G; Nadon F; Séguin C; Simard C; Lacroix M
    Arch Virol; 1991; 117(1-2):59-71. PubMed ID: 1706591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization of cotton rats with the fusion (F) and large (G) glycoproteins of respiratory syncytial virus (RSV) protects against RSV challenge without potentiating RSV disease.
    Murphy BR; Sotnikov A; Paradiso PR; Hildreth SW; Jenson AB; Baggs RB; Lawrence L; Zubak JJ; Chanock RM; Beeler JA
    Vaccine; 1989 Dec; 7(6):533-40. PubMed ID: 2692334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a simple, rapid, sensitive, high-throughput luciferase reporter based microneutralization test for measurement of virus neutralizing antibodies following Respiratory Syncytial Virus vaccination and infection.
    Fuentes S; Crim RL; Beeler J; Teng MN; Golding H; Khurana S
    Vaccine; 2013 Aug; 31(37):3987-94. PubMed ID: 23742994
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    van Erp EA; van Kasteren PB; Guichelaar T; Ahout IML; de Haan CAM; Luytjes W; Ferwerda G; Wicht O
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28794038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protective antigenic sites in respiratory syncytial virus G attachment protein outside the central conserved and cysteine noose domains.
    Lee J; Klenow L; Coyle EM; Golding H; Khurana S
    PLoS Pathog; 2018 Aug; 14(8):e1007262. PubMed ID: 30142227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of a synthetic peptide as part of a major neutralization epitope of respiratory syncytial virus.
    Trudel M; Nadon F; Seguin C; Dionne G; Lacroix M
    J Gen Virol; 1987 Sep; 68 ( Pt 9)():2273-80. PubMed ID: 2443612
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of subgroups of bovine respiratory syncytial virus.
    Baker JC; Wilson EG; McKay GL; Stanek RJ; Underwood WJ; Velicer LF; Mufson MA
    J Clin Microbiol; 1992 May; 30(5):1120-6. PubMed ID: 1583108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biological activity, binding site and affinity of monoclonal antibodies to the fusion protein of respiratory syncytial virus.
    West WH; Lounsbach GR; Bourgeois C; Robinson JW; Carter MJ; Crompton S; Duhindan N; Yazici ZA; Toms GL
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2813-9. PubMed ID: 7931172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased susceptibility of human respiratory syncytial virus to neutralization by anti-fusion protein antibodies on adaptation to replication in cell culture.
    Marsh R; Connor A; Gias E; Toms GL
    J Med Virol; 2007 Jun; 79(6):829-37. PubMed ID: 17457900
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.
    McGinnes Cullen L; Schmidt MR; Kenward SA; Woodland RT; Morrison TG
    J Virol; 2015 Jul; 89(13):6835-47. PubMed ID: 25903340
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.